• 17333 Citations
1978 …2022
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Education/Academic qualification

Bioinorganic Chemistry, PhD, Columbia University

… → 1985

Bioinorganic Chemistry, MA, University of Missouri, Columbia

… → 1980

Chemistry, BS, University of Missouri, Columbia

… → 1979

Fingerprint Dive into the research topics where Thomas V O'Halloran is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Copper Medicine & Life Sciences
Zinc Medicine & Life Sciences
Metals Medicine & Life Sciences
Metallochaperones Medicine & Life Sciences
Proteins Medicine & Life Sciences
Ions Medicine & Life Sciences
Superoxide Dismutase Medicine & Life Sciences
Platinum Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1998 2022

Research Output 1978 2019

1 Citation (Scopus)

Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent

Miodragović, D., Merlino, A., Swindell, E. P., Bogachkov, A., Ahn, R. W., Abuhadba, S., Ferraro, G., Marzo, T., Mazar, A. P., Messori, L. & O'Halloran, T. V., Apr 24 2019, In : Journal of the American Chemical Society. 141, 16, p. 6453-6457 5 p.

Research output: Contribution to journalArticle

Antineoplastic Agents
DNA
Arsenic
Cisplatin
Tumors

Bovine eggs release zinc in response to parthenogenetic and sperm-induced egg activation

Que, E. L., Duncan, F. E., Lee, H. C., Hornick, J. E., Vogt, S., Fissore, R. A., O'Halloran, T. V. & Woodruff, T. K., Mar 15 2019, In : Theriogenology. 127, p. 41-48 8 p.

Research output: Contribution to journalArticle

Eggs
Ovum
Spermatozoa
Zinc
zinc

Whole-body imaging of cell death provides a systemic, minimally invasive, dynamic, and near-real time indicator for chemotherapeutic drug toxicity

Johnson, S. E., Ugolkov, A., Haney, C. R., Bondarenko, G., Li, L., Waters, E. A., Bergan, R., Tran, A., O'Halloran, T. V., Mazar, A. & Zhao, M., Feb 15 2019, In : Clinical Cancer Research. 25, 4, p. 1331-1342 12 p.

Research output: Contribution to journalArticle

Whole Body Imaging
Drug-Related Side Effects and Adverse Reactions
Cell Death
Drug Therapy
Toxicology
2 Citations (Scopus)

9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma

Ugolkov, A. V., Bondarenko, G. I., Dubrovskyi, O., Berbegall, A. P., Navarro, S., Noguera, R., O'Halloran, T. V., Hendrix, M. J., Giles, F. J. & Mazar, A. P., Sep 1 2018, In : Anti-Cancer Drugs. 29, 8, p. 717-724 8 p.

Research output: Contribution to journalArticle

Glycogen Synthase Kinase 3
Neuroblastoma
irinotecan
Heterografts
Pediatrics
1 Citation (Scopus)

Aberrant expression of glycogen synthase kinase-3β in human breast and head and neck cancer

Ugolkov, A. V., Matsangou, M., Taxter, T. J., O'Halloran, T. V., Cryns, V. L., Giles, F. J. & Mazar, A. P., Nov 1 2018, In : Oncology Letters. 16, 5, p. 6437-6444 8 p.

Research output: Contribution to journalArticle

Glycogen Synthase Kinase 3
Head and Neck Neoplasms
Breast Neoplasms
Breast
Protein-Serine-Threonine Kinases